Study points to way of stopping lung cancer spread

By Will Dunham

WASHINGTON (Reuters) - Lung cancer cells produce a compound that helps the tumor spread to other parts of the body, a finding that could lead to a new way to prevent this dangerous development, researchers reported on Wednesday.

They said a protein called versican hijacks elements of the immune system, generating inflammation that can spur the growth and spread of lung cancer.

Michael Karin of the University of California, San Diego, and colleagues made the findings in experiments with mice, but said the protein is found in low levels in some normal human lung cells and other tissues.

Versican is made in large amounts by lung cancer cells, especially in aggressive tumors, they reported in the journal Nature.

Cancer becomes far more dangerous and hard to treat when it spreads from the original tumor site — the lungs in this study — to other parts of the body in a process called metastasis.

The researchers said their findings could lead to new treatments to limit the metastasis of lung cancer, perhaps by blocking the cancer cells from secreting the protein.

Versican was known to be involved in the development of embryos, and known to be active in some tumors, although its role was not clearly understood.

The study showed that versican causes the production of immune system proteins called cytokines, generating inflammation that fuels the growth and spread of the cancer.

“Our research showed that versican which (is) produced by cancer cells induced inflammatory response and this whole process enhances metastasis. This simply says that blocking versican or blocking the inflammatory response can reduce the metastatic incidence. However, it is not that easy,” Sunhwa Kim, one of the researchers, said by e-mail.

The immune system’s complexity is one hurdle, Kim said.

Kim, who previously worked in Karin’s lab and now works for Johnson & Johnson, called the findings a good starting point for human studies focusing on this protein.

Worldwide, lung cancer is the leading cause of cancer death in men and the second leading cause of cancer death in women, with about 975,000 men and 376,000 women dying annually, according to the American Cancer Society. About 1.5 million new cases of lung cancer occur per year.

(Editing by Maggie Fox and Xavier Briand)


Related Posts:

LONDON (Reuters) - The most commonly used breast cancer drug may cause tumors to spread in a small number of women with low levels of a protein which makes cells stick together, British researchers said on Thursday. The findings could lead to new tests to determine which women are not likely to benefit from tamoxifen and

Full Post: Study sheds light on breast cancer drug failure

By Megan Rauscher NEW YORK (Reuters Health) - Blocking certain proteins in cells may be a way to attack ovarian cancer, researchers said at the annual meeting of the American Society for Cell Biology underway in San Francisco. For growth and proliferation, ovarian cancer cells are “addicted” to a family of proteins produced by the cancer-promoting gene

Full Post: Possible way to treat ovarian cancer reported

By Julie Steenhuysen CHICAGO (Reuters) - A single gene appears to play a crucial role in deadly breast cancers, increasing the chances the cancer will spread and making it resistant to chemotherapy, U.S. researchers said on Monday. They found people with aggressive breast cancers have abnormal genetic alterations in a gene called MTDH, and drugs that block

Full Post: Scientists find a gene that makes cancer spread

CHICAGO (Reuters) - U.S. researchers have found a way to switch on a cell-killing protein in the body, a finding that could lead to new ways to treat diseases like cancer in which cells grow out of control. The body naturally activates this protein, called BAX, to kill off unwanted or defective cells in a process

Full Post: Researchers find trigger for killer protein

By Michael Kahn LONDON (Reuters) - British scientists have figured out why some women develop resistance to the most commonly used breast cancer drug, something that raises the risk their tumors will return, according to a study published on Wednesday. The findings could lead to new tests to determine which women are not likely to benefit from

Full Post: Scientists unravel breast cancer drug resistance

Site Navigation

Most Read